Perspective
Nature Reviews Cancer 5, 135-141 (February 2005) | doi:10.1038/nrc1548
Innovation: Control of DNA replication and its potential clinical exploitation
Michael A. Gonzalez, Kiku-e K. Tachibana1, Ronald A. Laskey1 About the authors & Nicholas Coleman1
Abstract
Multiple conserved mechanisms limit DNA replication to once per cell cycle. One vital level of control focuses on the loading of the heterohexameric ring of minichromosome maintenance proteins (MCMs) onto chromatin in the hierarchical assembly of the pre-replication complex at origins of replication. An essential role in proliferation for MCMs and their regulators makes them potentially important biomarkers for routine clinical use in cancer detection and prognosis.
Author affiliations
- Michael A. Gonzalez, Kiku-e K. Tachibana, Ronald A. Laskey and Nicholas Coleman are at the Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK.
Correspondence to: Nicholas Coleman1 Email: nc109@cam.ac.uk
Correspondence to: Michael A. Gonzalez Email: mg322@cam.ac.uk
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Geminin bans replication licenceNature Cell Biology News and Views (01 Feb 2001)
Many roads lead to the originNature Cell Biology News and Views (01 Mar 2002)
See all 3 matches for News And ViewsRESEARCH
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphomaBritish Journal of Cancer Original Article
DNA replication licensing and cell cycle kinetics of normal and neoplastic breastBritish Journal of Cancer Original Article
See all 61 matches for Research